Identification and validation of an immunological microenvironment signature and prediction model for epstein-barr virus positive lymphoma: Implications for immunotherapy

BACKGROUND: Epstein-Barr virus (EBV) is considered a carcinogenic virus, which is associated with high risk for poor prognosis in lymphoma patients, and there has been especially no satisfying and effective treatment for EBV+ lymphoma. We aimed to identify the immunological microenvironment molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Chenjiao, Xu, Ruoyao, Li, Qianyuan, Xiao, Sheng, Hu, Min, Xu, Linyong, Zhuang, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559214/
https://www.ncbi.nlm.nih.gov/pubmed/36249005
http://dx.doi.org/10.3389/fonc.2022.970544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559214/
https://www.ncbi.nlm.nih.gov/pubmed/36249005
http://dx.doi.org/10.3389/fonc.2022.970544

Ejemplares similares